Page 49 - Portuguese Journal - SPORL - Vol 61. Nº2
P. 49

Table 7
           Primary treatment modalities

          Treatment                                                              Number of patients (%)

          Surgical treatment                                                            16 (84.2%)
          Surgery alone                                                                 4 (21.1%)

          Surgery + radiotherapy                                                        10 (52.6%)
          Surgery + chemoradiotherapy                                                   2 (10.5%)

          Non-surgical treatment                                                        3 (15.8%)
          Radiotherapy                                                                   1 (5.3%)

          Chemoradiotherapy                                                              1 (5.3%)

          Chemotherapy                                                                   1 (5.3%)

           Table 8
           Histology, initial TNM staging and local of recurrence for patients with recurrent disease

          Histology                         Staging (TNM)                     Recurrence

                                                               Local (premaxillary skin, maxillary bone, hard
          Squamous cell carcinoma              T1N0M0
                                                                        palate, nasal cavity floor)
          Neuroendocrine tumors                T4bN0M0                   Distance (epicranium)
          Mucosal malignant melanoma           T3N0M0                       Distance (lung)

          Mucosal malignant melanoma           T3N1M0                      Local (hard palate)
          Adenoid cystic carcinoma             T4bN0M0                      Distance (lungs)



          (range from 2-71 months). Recurrent disease       =  0.025,  figure  1a),  as  well  as  DFS  (p  =  0.025,
          occurred in 5 patients (26.3%), being local in 3   figure 1b). While patients with T3, T4a or T4b
          patients and metastatic in 2 patients. In table   tumors had worse prognosis compared with
          8 is summarized the histology, initial TNM        T1 patients, the difference was not statistically
          staging and the local of recurrence.              significant  (p  =  0.092,  figure  1c).  Primary
          Five-year  overall  survival  (OS)  was  53.5%  and   treatment  modality  significantly  influenced
          disease-free survival (DFS) was 62.8%. History    survival (p = 0.002), with surgical therapy
          of previous tumors was statistically associated   showing  a  statistically  significant  difference
          with worse prognosis (p < 0.001), while smoke     compared to nonsurgical treatments (p < 0.001).
          (p = 0.733), alcohol consumption (p = 0.205) or   In patients submitted to surgical  treatment,
          occupational risk factors (p = 0.584) did not     there was no statistically significant difference
          affect  prognosis.  Patients  with  nonepithelial   in 5-year OS between external approach and
          tumors had worse prognosis compared with          endonasal endoscopic approach (p = 0.724).
          patients with epithelial tumors, despite the      Although the presence of microscopically
          difference  was  not  statistically  significant  (p   positive margins was associated with worse
          = 0.230).  N component of TNM staging for         prognosis, the difference was not statistically
          epithelial and mucosal melanoma tumors            significant (p = 0.123).
          significantly affected 5-year OS, with positive
          nodes associated with worse prognosis (p


                                                                                      Volume 61 . Nº2 . June 2023 191
   44   45   46   47   48   49   50   51   52   53   54